fbpx

Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD – GuruFocus.com

Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD  GuruFocus.comSAN FRANCISCO and TEL AVIV, Israel, March 22,…

Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD – GuruFocus.com Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD  GuruFocus.com

SAN FRANCISCO and TEL AVIV, Israel, March 22, 2019 (GLOBE NEWSWIRE) — KalyteraTherapeutics, Inc. (TSX VENTURE: KALY and KALTF) (the “Company” …

বাংলা简体中文繁體中文EnglishFrançaisDeutschहिन्दीItaliano日本語한국어मराठीPortuguêsਪੰਜਾਬੀРусскийEspañolSvenskaతెలుగుไทยTürkçeУкраїнськаTiếng Việt